Skip to main content
Top
Published in: Journal of Gastrointestinal Cancer 2/2013

01-06-2013 | Letter to the Editor

Obstructive Jaundice as Recurrence of Lung Adenocarcinoma

Authors: Kensuke Nakazawa, Tomohiro Tamura, Shinya Sato, Katsunori Kagohashi, Koichi Kurishima, Hiroaki Satoh

Published in: Journal of Gastrointestinal Cancer | Issue 2/2013

Login to get access

Excerpt

Adenocarcinoma is the most common form of lung cancer [1]. Metastatic potential is a feature, with frequent widespread dissemination and multiple synchronous visceral involvements even at diagnosis [2]. However, the frequency of manifestations related to obstructive jaundice is low [3, 4]. Obstructive jaundice with highly elevated serum concentrations of transaminase can be occasionally observed, but it is most commonly determined by diffuse liver parenchymal involvement. A few cases of extrahepatic jaundice due to abdominal lymph nodes involvement or pancreatic metastasis by lung cancer, mostly small cell type [57], have been reported [37]. We show here that ERCP could manage this particular clinical condition safely. …
Literature
2.
go back to reference Ruckdeschel JC, Schwartz AG, Bepler G, Coppage L, Lonardo F, Kucuk O, et al. Cancer of the lung: NSCLC and SCLC. In: Abeloff MD, Armitage JO, Niederhuber JE, Kastan MB, McKenna WG, editors. Clinical oncology. Philadelphia: Elsevier; 2004. p. 1649–743. Ruckdeschel JC, Schwartz AG, Bepler G, Coppage L, Lonardo F, Kucuk O, et al. Cancer of the lung: NSCLC and SCLC. In: Abeloff MD, Armitage JO, Niederhuber JE, Kastan MB, McKenna WG, editors. Clinical oncology. Philadelphia: Elsevier; 2004. p. 1649–743.
3.
go back to reference Perfetti V, Markopoulos K, Maffè GC, Picheo R, Corazza GR. Juxtapapillary pancreatic metastasis with obstructive jaundice as isolated recurrence of lung adenocarcinoma. Dig Liver Dis. 2008;40:230–1.PubMedCrossRef Perfetti V, Markopoulos K, Maffè GC, Picheo R, Corazza GR. Juxtapapillary pancreatic metastasis with obstructive jaundice as isolated recurrence of lung adenocarcinoma. Dig Liver Dis. 2008;40:230–1.PubMedCrossRef
4.
go back to reference Pericleous S, Mukherjee S, Hutchins RR. Lung adenocarcinoma presenting as obstructive jaundice: a case report and review of literature. World J Surg Oncol. 2008;6:120.PubMedCrossRef Pericleous S, Mukherjee S, Hutchins RR. Lung adenocarcinoma presenting as obstructive jaundice: a case report and review of literature. World J Surg Oncol. 2008;6:120.PubMedCrossRef
5.
go back to reference Johnson DH, Hainsworth JD, Greco FA. Extrahepatic biliary obstruction caused by small-cell lung cancer. Ann Intern Med. 1985;102:487–90.PubMedCrossRef Johnson DH, Hainsworth JD, Greco FA. Extrahepatic biliary obstruction caused by small-cell lung cancer. Ann Intern Med. 1985;102:487–90.PubMedCrossRef
6.
go back to reference Howe Jr HR, Hansen KJ, Albertson DA. Metastatic oat cell carcinoma of the lung producing extrahepatic bile duct obstruction. South Med J. 1985;78:1398–9.PubMedCrossRef Howe Jr HR, Hansen KJ, Albertson DA. Metastatic oat cell carcinoma of the lung producing extrahepatic bile duct obstruction. South Med J. 1985;78:1398–9.PubMedCrossRef
7.
go back to reference Liratzopoulos N, Efremidou EI, Papageorgiou MS, Romanidis K, Minopoulos GJ, Manolas KJ. Extrahepatic biliary obstruction due to a solitary pancreatic metastasis of squamous cell lung carcinoma. Case report. J Gastrointest Liver Dis. 2006;15:73–5. Liratzopoulos N, Efremidou EI, Papageorgiou MS, Romanidis K, Minopoulos GJ, Manolas KJ. Extrahepatic biliary obstruction due to a solitary pancreatic metastasis of squamous cell lung carcinoma. Case report. J Gastrointest Liver Dis. 2006;15:73–5.
8.
go back to reference Obara M, Satoh H, Yamashita YT, Kamma H, Ohtsuka M, Hasegawa S, et al. Metastatic small cell lung cancer causing biliary obstruction. Med Oncol. 1998;15:292–4.PubMedCrossRef Obara M, Satoh H, Yamashita YT, Kamma H, Ohtsuka M, Hasegawa S, et al. Metastatic small cell lung cancer causing biliary obstruction. Med Oncol. 1998;15:292–4.PubMedCrossRef
Metadata
Title
Obstructive Jaundice as Recurrence of Lung Adenocarcinoma
Authors
Kensuke Nakazawa
Tomohiro Tamura
Shinya Sato
Katsunori Kagohashi
Koichi Kurishima
Hiroaki Satoh
Publication date
01-06-2013
Publisher
Springer US
Published in
Journal of Gastrointestinal Cancer / Issue 2/2013
Print ISSN: 1941-6628
Electronic ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-012-9436-8

Other articles of this Issue 2/2013

Journal of Gastrointestinal Cancer 2/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine